Welcome to our dedicated page for QT Imaging Holdings SEC filings (Ticker: qti), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QT Imaging Holdings’ filings rarely read like light bedtime material—dense R&D tables, FDA language, and complex revenue breakouts can stretch past 200 pages. If you have ever searched “QT Imaging Holdings SEC filings explained simply” or wondered why an 8-K suddenly appears after a device-clearance press release, you already know the challenge.
Stock Titan solves this problem. Our AI breaks down each QT Imaging Holdings annual report 10-K simplified into clear sections: R&D spend for next-gen ultrasound, licensing royalties, and backlog of imaging system orders. Need the newest numbers? The platform pulls every QT Imaging Holdings quarterly earnings report 10-Q filing the moment it hits EDGAR and adds plain-English summaries of revenue by segment. Material events such as FDA submissions land as “QT Imaging Holdings 8-K material events explained” notifications, so you never miss a regulatory milestone.
Curious about management’s confidence? Track QT Imaging Holdings insider trading Form 4 transactions in real time. Our dashboards flag patterns like option exercises or clustered sales, while keyword links—“QT Imaging Holdings Form 4 insider transactions real-time” and “QT Imaging Holdings executive stock transactions Form 4”—take you straight to the filings. For governance research, the QT Imaging Holdings proxy statement executive compensation shows pay tied to imaging system sales benchmarks, and AI highlights the metrics that move bonuses.
Whether you are benchmarking R&D efficiency, modeling service-contract margins, or simply understanding QT Imaging Holdings SEC documents with AI, our platform delivers: comprehensive coverage of every form, instant alerts, and expert analysis that turns raw disclosures into actionable clarity.
Jay Walter Jennings, identified as a Director and Chief Financial Officer of QT Imaging Holdings (ticker QTI), filed an Initial Statement of Beneficial Ownership on 09/02/2025. The filing discloses a stock option covering 325,000 shares of common stock with an exercise price of $1.90 and an indicated expiration date of 09/02/2035. The option vests one-third on August 15, 2026 with the remaining two-thirds vesting in eight equal quarterly installments and fully vesting on August 15, 2028, subject to continued service.
Anastas Budagov, identified as Chief Financial Officer of QT Imaging Holdings, Inc. (QTIH), filed a Form 4 stating his insider status terminated as of August 29, 2025. The filing shows no reported non-derivative or derivative transactions on the form and notes the reporting person is no longer subject to Section 16 obligations following that termination.
Alta Partners LLC reported beneficial ownership of 1,698,704 shares of QT Imaging Holdings, Inc. common stock, representing 5.58% of the class. The filing states these shares are "shares issuable upon exercise of warrants," and Alta Partners reports sole voting and dispositive power over all 1,698,704 shares. The statement affirms the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing is submitted on Schedule 13G and signed by Steven Cohen as Managing Member of Alta Partners LLC.
QT Imaging Holdings’ Second Amended and Restated Certificate of Incorporation, effective March 4, 2024, grants broad indemnification to current and former directors, officers, employees and agents to the fullest extent permitted by law. The Charter and cited Delaware law (Section 145 of the DGCL) allow the company to pay or advance expenses, including attorneys’ fees, judgments, fines, ERISA excise taxes and settlement amounts, for persons involved in threatened, pending or completed proceedings arising from service to the company or at its request for other entities. The DGCL also expressly permits insurance to cover such liabilities. The filing restates that indemnification rights are nonexclusive and confirms advancement of defense expenses subject to applicable law.
QT Imaging Holdings, Inc. disclosed the appointment of Michael Jennings as Chief Financial Officer with a CFO employment agreement that provides, if terminated without a Change of Control and upon an effective release of claims, nine months of his then-current base salary paid monthly, continuation of company-paid health coverage for up to nine months (or until he begins comparable full-time coverage), and immediate vesting of equity awards through the next scheduled vesting date. Mr. Jennings, age 58, is a CPA with senior finance experience at UpHealth and eHealth and has led finance, SEC reporting, and large system implementations.
The company also announced a Warrant Repurchase Agreement providing $5.0 million in new funding to repurchase and cancel Yorkville warrants, as disclosed in press releases attached as exhibits.
Zeev Weiner, a director of QT Imaging Holdings, Inc. (QTI/QTIH), was granted 25,000 stock options on 08/11/2025 with an exercise price of $1.90. The option award is reported as a direct holding and the filing shows 25,000 derivative securities beneficially owned following the transaction.
The grant vests one-third on August 15, 2026, with the remaining two-thirds vesting in eight equal quarterly installments on each November 15, February 15, May 15 and August 15, resulting in full vesting on August 15, 2028, subject to continued service. The Form 4 is signed by Zeev Weiner on 08/13/2025 and lists an expiration date of 08/11/2035 for the option term as reported.
FAQ
What is the current stock price of QT Imaging Holdings (qti)?
What is the market cap of QT Imaging Holdings (qti)?
